Skip to main content

Raymond James Invests in Service Excellence with Proprietary Generative AI Search

ST. PETERSBURG, Fla., April 17, 2025 (GLOBE NEWSWIRE) — Raymond James continues its investment in artificial intelligence as a crucial component of service excellence with the launch of its proprietary AI Search technology. Powered by generative artificial intelligence, AI Search enables both financial advisors and associates to ask intuitive, natural language questions to the firm’s vast internal knowledge base and receive precise, tailored information in return, according to Stuart Feld, newly appointed chief artificial intelligence officer. “Part of our commitment to advisors is to invest in innovation that will enhance the firm’s already industry-leading service levels and return more of their most precious asset to them – time. AI Search reduces time spent scanning search results into a one-stop question and answer experience...

Continue reading

MultiCorp International, Inc. Announces that Strategic Partner Neoforma, Inc. has received $2 Billion Credit Transfer Receipt per April 14, 2025 press release announcing Quadrpartitie Agreement.

AGOURA HILLS, CALIFORNIA, April 17, 2025 (GLOBE NEWSWIRE) — MultiCorp International, Inc. (OTC Markets PINK: MCIC) Multicorp International, Inc. is pleased to announce that Neoforma Inc. has received the $2,000,000,000 credit transfer receipt from Airavata Developers Corporation’s top 10 European Bank this morning. Multicorp International, Inc.’s alliance with 40 Brightwater LLC’s Global Financial Consortium inclusive of Neoforma Inc. and now Airavata Developers Corporation has expanded immediate access to greater liquidity, which will be added to the previously announced financings from Edwards Capital N.A. correspondent bank. In turn, Neoforma Inc. will provide a line of credit to MultiCorp International, Inc. in an amount of up to $1,800,000,000 (one billion eight hundred million USD), to be utilized to execute...

Continue reading

Form 8.3 – [SCIENCE IN SPORT PLC – Opening Disclosure – 16 04 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SCIENCE IN SPORT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

VANTIVA: 2024 Universal Registration Document available

Press Release     VANTIVA: 2024 Universal Registration Document available Paris (France) – April 17, 2025 – Vantiva (Euronext Paris: VANTI), a global technology leader in connectivity, Vantiva informs that its 2024 Universal Registration Document (Document d’Enregistrement Universel) has been filed with the French Autorité des Marchés Financiers (AMF) on April 17, 2025. It has been prepared in European Single Electronic Format (ESEF) and includes the annual financial report, the corporate governance report of the Board of Directors, the sustainability report, the statutory auditors’ reports and details of their fees. The Universal Registration Document in French version is available on the Group’s website https://www.vantiva.com/fr/relations-investisseurs/informations-reglementees, and at its corporate head office: 10 Boulevard...

Continue reading

Form 8.3 – [ALLIANCE PHARMA PLC – 16 04 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ALLIANCE PHARMA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

[ADVANCED MEDICAL SOLUTIONS GROUP PLC – 16 04 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Psyence Group Announces Share Consolidation

TORONTO, April 17, 2025 (GLOBE NEWSWIRE) — Psyence Group Inc. (“Psyence Group” or the “Company“) (CSE: PSYG), announces that the Company will be consolidating all of its issued and outstanding share capital (the “Common Shares“) on the basis of every fifteen (15) old Common Shares into one (1) new Common Share (the “Share Consolidation“), effective April 23, 2025 with a record date of April 23, 2025 (the “Record Date“). As a result of the Share Consolidation, the issued and outstanding Common Shares will be reduced to approximately 9,387,695 on the effective date of April 23, 2025. No fractional shares will be issued as a result of the Share Consolidation. All fractions of Common Shares will be rounded down to the next lowest whole number. No cash consideration will be...

Continue reading

Form 8.3 – Life Science REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Life Science REIT Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Continue reading

New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery

Studies show robotic-assisted procedures enable increased access to minimally invasive care SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Intuitive (NASDAQ: ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), today announced the publication of two studies showing how the availability of RAS helps enable access to high-quality care, improve patient outcomes, particularly in medical deserts, and contributes to the overall growth of minimally invasive care ultimately benefitting patients. The studies, published in the Journal of the Society of Laparoscopic & Robotic Surgeons and Annals of Surgery Open, are part of broader research underway by Intuitive to evaluate the availability and impact of RAS. As a leader in minimally invasive care, Intuitive is committed to identifying...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.